Cargando…

COVID-19 and shielding: experiences of UK patients with lupus and related diseases

OBJECTIVE: The shielding guidance in the UK for the clinically extremely vulnerable (CEV) commenced on 23 March 2020 in response to the coronavirus disease 2019 (COVID-19) pandemic. The purpose of this study was to explore the impact of the pandemic and shielding on patients with lupus and related s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sloan, Melanie, Gordon, Caroline, Lever, Elliott, Harwood, Rupert, Bosley, Michael A, Pilling, Mark, Brimicombe, James, Naughton, Felix, Blane, Moira, Walia, Chanpreet, D’Cruz, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928599/ https://www.ncbi.nlm.nih.gov/pubmed/33728396 http://dx.doi.org/10.1093/rap/rkab003

Ejemplares similares

‘But you don’t look sick’: a qualitative analysis of the LUPUS UK online forum
por: Sloan, Melanie, et al.
Publicado: (2020)

Is it me? The impact of patient–physician interactions on lupus patients’ psychological well-being, cognition and health-care-seeking behaviour
por: Sloan, Melanie, et al.
Publicado: (2020)

The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study
por: Sloan, Melanie, et al.
Publicado: (2020)

Will ‘the feeling of abandonment’ remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and clinicians
por: Sloan, Melanie, et al.
Publicado: (2022)

Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians
por: Sloan, Melanie, et al.
Publicado: (2021)

Medication decision-making and adherence in lupus: patient–physician discordance and the impact of previous ‘adverse medical experiences’
por: Sloan, Melanie, et al.
Publicado: (2021)

Medically explained symptoms: a mixed methods study of diagnostic, symptom and support experiences of patients with lupus and related systemic autoimmune diseases
por: Sloan, Melanie, et al.
Publicado: (2020)

Clinical observation: are nightmares a manifestation of neuropsychiatric lupus?
por: D’Cruz, David P, et al.
Publicado: (2022)

Study protocol for iQuit in Practice: a randomised controlled trial to assess the feasibility, acceptability and effectiveness of tailored web- and text-based facilitation of smoking cessation in primary care
por: Sutton, Stephen, et al.
Publicado: (2013)

Assessment of the Effectiveness and Cost-Effectiveness of Tailored Web- and Text-Based Smoking Cessation Support in Primary Care (iQuit in Practice II): Protocol for a Randomized Controlled Trial
por: Proctor, Joanna, et al.
Publicado: (2020)

Current and emerging treatment options in the management of lupus
por: Jordan, Natasha, et al.
Publicado: (2016)

Randomized controlled trial to assess the short-term effectiveness of tailored web- and text-based facilitation of smoking cessation in primary care (iQuit in Practice)
por: Naughton, Felix, et al.
Publicado: (2014)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Editorial: Cutting edge in systemic lupus erythematosus
por: D’Cruz, David P., et al.
Publicado: (2017)

Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study
por: Browne, Jorge, et al.
Publicado: (2017)

Towards Precision Medicine in Systemic Lupus Erythematosus
por: Lever, Elliott, et al.
Publicado: (2020)

Topical calcineurin inhibitors in systemic lupus erythematosus
por: Lampropoulos, Christos E, et al.
Publicado: (2010)

Intravenous Immunoglobulin in the Therapeutic Armamentarium of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2014)

Shielded Coaxial Optrode Arrays for Neurophysiology
por: Naughton, Jeffrey R., et al.
Publicado: (2016)

Novel therapeutic agents in clinical development for systemic lupus erythematosus
por: Jordan, Natasha, et al.
Publicado: (2013)

British isles lupus assessment group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus
por: Yee, Chee-Seng, et al.
Publicado: (2007)

Impact of COVID-19 on Obesity Management Services in the United Kingdom (The COMS-UK study)
por: Moussa, Osama, et al.
Publicado: (2020)

Smoking Cessation Support by Text Message During Pregnancy: A Qualitative Study of Views and Experiences of the MiQuit Intervention
por: Sloan, Melanie, et al.
Publicado: (2017)

Individuals living with lupus: findings from the LUPUS UK Members Survey 2014
por: Morgan, C, et al.
Publicado: (2018)

Cytokines in systemic lupus erythematosus, London, UK
por: Rahman, Anisur
Publicado: (2003)

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
por: Yee, Chee-Seng, et al.
Publicado: (2011)

Contrast enhancement imaging in coronary arteries in patients with systemic lupus erythematosus
por: Puntmann, Valentina O, et al.
Publicado: (2012)

Hybrid structure of MWCNT/ferrite and GO incorporated composites for microwave shielding properties and their practical applications
por: Kumar, Sumit, et al.
Publicado: (2021)

Are Nurses and Auxiliary Healthcare Workers Equally Effective in Delivering Smoking Cessation Support in Primary Care?
por: Faulkner, Kathryn, et al.
Publicado: (2016)

Understanding the impact of systemic lupus erythematosus on work amongst South Asian people in the UK: An explorative qualitative study
por: Ubhi, Mandeep, et al.
Publicado: (2021)

Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1
por: Lewis, Myles J., et al.
Publicado: (2016)

Long-term preservation of biomolecules in lake sediments: potential importance of physical shielding by recalcitrant cell walls
por: Han, Xingguo, et al.
Publicado: (2022)

SC shielding : under the Neutron Room shielding platform
por: CERN PhotoLab
Publicado: (1959)

On shielding estimates for magnetic and non-magnetic shield materials
por: Dahlberg, E D
Publicado: (1975)

A lightweight magnetically shielded room with active shielding
por: Holmes, Niall, et al.
Publicado: (2022)

Shield your slit lamp with a face shield!
por: Singh, Atul Kumar, et al.
Publicado: (2022)

‘We thank you for your sacrifice’: Clinical vulnerability, shielding and biosociality in the UK’s Covid-19 response
por: Herrick, Clare
Publicado: (2022)

Correction to: Assessing the acceptability of a text messaging service and smartphone app to support patient adherence to medications prescribed for high blood pressure: a pilot study
por: Kassavou, Aikaterini, et al.
Publicado: (2020)

Open dialogue in the UK: qualitative study
por: Tribe, Rachel H., et al.
Publicado: (2019)

Comparison of Shielding Material Dispersion Characteristics and Shielding Efficiency for Manufacturing Medical X-ray Shielding Barriers
por: Kim, Seon-Chil
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dh871t4i0ncosjn8v0rj88nu7a